FDA Interoperability Designation-Creating Options for People With Diabetes and Pump Companies: Regulatory, Technological, and Commercial Perspectives.
IF 4.1
Q2 ENDOCRINOLOGY & METABOLISM
引用次数: 0
FDA 互操作性指定--为糖尿病患者和泵公司创造选择：监管、技术和商业视角。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
求助全文
约1分钟内获得全文
求助全文
来源期刊
Journal of Diabetes Science and Technology
Medicine-Internal Medicine
CiteScore
7.50
自引率
12.00%
发文量
148
期刊介绍：
The Journal of Diabetes Science and Technology (JDST) is a bi-monthly, peer-reviewed scientific journal published by the Diabetes Technology Society. JDST covers scientific and clinical aspects of diabetes technology including glucose monitoring, insulin and metabolic peptide delivery, the artificial pancreas, digital health, precision medicine, social media, cybersecurity, software for modeling, physiologic monitoring, technology for managing obesity, and diagnostic tests of glycation. The journal also covers the development and use of mobile applications and wireless communication, as well as bioengineered tools such as MEMS, new biomaterials, and nanotechnology to develop new sensors. Articles in JDST cover both basic research and clinical applications of technologies being developed to help people with diabetes.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
